NovaBridge Biosciences

Predicción y previsión de precio de NovaBridge Biosciences (NBP)

$1.840

-0.049 (-2.65%)Al cierre

Predicciones de precio

1-Day Price Prediction
-1.63%
1-Week Prediction
-1.56%
1-Month Prediction
2026 Prediction
2030 Prediction

Ábrelo en la app para desbloquear previsiones a más largo plazo.

Loading chart…

Predicción y previsión de NBP por análisis de gráficos similares

Alphio's NBP stock price prediction model matches the current NovaBridge Biosciences tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.81 (-1.63%). The 1-week path is $1.81 (-1.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

¿Debería comprar acciones de NovaBridge Biosciences?

Currently, NovaBridge Biosciences is not a strong buy. The stock is priced at 1.84, with a significant year-to-date change of -56.91%. Although the company has $216 million in cash, it reported a widening net loss of $37.9 million for the first half of 2026, indicating financial instability. The RSI is at 41.9, suggesting the stock is nearing oversold territory but still lacks strong upward momentum. The main risk is the projected EPS loss of -0.14 for the next quarter, which could further impact investor sentiment.

NBP cerró en $1.84 el Friday, tras bajar -2.65%

NovaBridge Biosciences (NBP) last closed at $1.84, losing -2.65%. These facts feed the 1-day and 1-week NBP price prediction above.

Factores de la previsión

Los factores de la previsión de NovaBridge Biosciences (NBP) combinan patrones gráficos similares, estacionalidad y medias móviles.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Patrones gráficos similares

Acciones cuya trayectoria reciente más se parece a la de NBP, ordenadas por similitud.

Análisis de estacionalidad de NBP

Loading chart…

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis